Cargando…
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake–Independent Metabolic Benefits in Diet-Induced Obese Rats
OBJECTIVE—Blockade of the CB1 receptor is one of the promising strategies for the treatment of obesity. Although antagonists suppress food intake and reduce body weight, the role of central versus peripheral CB1 activation on weight loss and related metabolic parameters remains to be elucidated. We...
Autores principales: | Nogueiras, Ruben, Veyrat-Durebex, Christelle, Suchanek, Paula M., Klein, Marcella, Tschöp, Johannes, Caldwell, Charles, Woods, Stephen C., Wittmann, Gabor, Watanabe, Masahiko, Liposits, Zsolt, Fekete, Csaba, Reizes, Ofer, Rohner-Jeanrenaud, Francoise, Tschöp, Matthias H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570394/ https://www.ncbi.nlm.nih.gov/pubmed/18716045 http://dx.doi.org/10.2337/db08-0161 |
Ejemplares similares
-
Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
por: Poher, Anne-Laure, et al.
Publicado: (2015) -
Central Glucocorticoid Administration Promotes Weight Gain and Increased 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in White Adipose Tissue
por: Veyrat-Durebex, Christelle, et al.
Publicado: (2012) -
Improved Leptin Sensitivity as a Potential Candidate Responsible for the Spontaneous Food Restriction of the Lou/C Rat
por: Veyrat-Durebex, Christelle, et al.
Publicado: (2013) -
Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet
por: Poher, Anne-Laure, et al.
Publicado: (2016) -
Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
por: Lockie, Sarah H., et al.
Publicado: (2012)